胸腺肽α1对血液透析患者微炎症状态的干预研究.pdfVIP

下载本文档

2
0
约 52页
2017-09-06 发布于安徽
举报
版权申诉

胸腺肽α1对血液透析患者微炎症状态的干预研究.pdf

1、本文档共52页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

目录中文摘要 ···················································1 英文摘要 ···················································3 引言 ····················································6 正文 ····················································7 1 资料与方法 ·················································7 1.1研究对象 ··················································7 1.1.1 病例来源 ·················································7 1.1.2 诊断标准 ·················································7 1.1.3 纳入标准 ·················································7 1.1.4 排除标准 ·················································8 1.1.5 脱落标准 ·················································8 1.2 研究方法 ···············································8 1.2.1 分组方法 ················································8 1.2.2 透析方法 ················································9 1.2.3 治疗方法 ················································9 1.2.4 观察指标 ·················································9 1.2.5 检测方法 ···············································10 1.2.6 统计学处理 ·············································13 2 研究结果 ················································13 2.1 一般情况 ··············································13 2.2 MHD 患者炎症状态的情况 ··································14 2.3 两组MHD 患者治疗前后血清炎症指标比较 ···················14 2.4 两组MHD 患者治疗前后一般生化指标及Hb 比较 ···············15 3 讨论 ·····················································16 3 .1M HD 患者的微炎症状态 ·······························16 3 .2M HD 患者慢性微炎症状态发生的原因及机制 ··········18 3.3 微炎症状态的临床监测指标 ···························22 3.4 微炎症状态存在的临床意义 ···························24 3.5 目前微炎症预防和治疗方法 ···························27 3.6 胸腺肽 α 1 药理研究及临床应用 ·······················29 3 .7 胸腺肽 α 1 对微炎症状态的作用机制〃··················29 4 存在的问题和展望 ······································32 结论 ··················································3 4 参考文献 ··················································3 5 综述 ·······